3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Small Cell Lung Carcinoma
9
Carcinoma, Non-Small-Cell Lung
7
Sarcoma
5
Breast Neoplasms
4
Triple Negative Breast Neoplasms
3
Nasopharyngeal Carcinoma
3
Thyroid Neoplasms
2
Pancreatic Neoplasms
2
Neoplasm Metastasis
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma, Renal Cell
2
Carcinoma, Hepatocellular
2
Whole-Brain Radiotherapy
1
Stomach Neoplasms
1
Solid Tumors
1
Small Cell Lung Cancer Extensive Stage
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Recurrence
1
Proteinuria
1
Progression Free Survival(PFS)
1
Platinum-resistant Ovarian Cancer (PROC)
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Leiomyosarcoma
1
HER2-Negative Breast Cancer
1
Gallbladder Neoplasms
1
Fallopian Tube Neoplasms
1
Extensive Stage Lung Small Cell Cancer
1
Esophageal Neoplasms
1
Interventions
Injections
20
Carboplatin
9
pembrolizumab
8
Bevacizumab
6
Pemetrexed
5
Paclitaxel
5
Leucovorin
5
Fluorouracil
5
fludarabine
4
Oxaliplatin
4
Docetaxel
4
sotorasib
3
atezolizumab
3
Drug Therapy
3
Cyclophosphamide
3
Capecitabine
3
trifluridine tipiracil drug combination
2
trametinib
2
toripalimab
2
spartalizumab
2
palbociclib
2
olaparib
2
Panitumumab
2
Immune Checkpoint Inhibitors
2
Fulvestrant
2
Etoposide
2
Cisplatin
2
Cetuximab
2
130-nm albumin-bound paclitaxel
2
zimberelimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Advanced Solid Tumors
×
anlotinib
×
1 year
×
Clear all
No trials found.